Clinical Trial Update: A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis [Phase 3]

View source ↗

Summary

A Phase 3B study is evaluating bone mineral density with long-term Relugolix combination tablet use in women with uterine fibroids or endometriosis and is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis
• Uterine Fibroids

Drugs mentioned

• Relugolix combination tablet (relugolix)

Snippet

Sponsor: Sumitomo Pharma Switzerland GmbH | Conditions: Uterine Fibroids, Endometriosis | Phase 3 | Status: RECRUITING